The Cooper Heart Institute at Cooper University Hospital has been selected as one of the initial sites in the United States to implement a![\"\"](\"http://blogs.cooperhealth.org/news/files/2011/12/valve-team.jpg\")
groundbreaking cardiovascular technology, the new Sapien Percutaneous Heart Valve.
This technology is expected to transform the treatment of aortic stenosis and aortic valve disease, which affects nearly 300,000 people annually in the United States. The transcatheter valve provides a non-surgical, catheter-based repair option for patients who are unable to undergo surgery for their aortic disease. The Sapien valve will be one of the advanced therapeutic options available at the new comprehensive, multi-disciplinary Cooper Heart Valve Center.
Cooper is the only site in southern New Jersey that
This post was imported from a legacy archive. Please excuse any formatting inconsistencies.